{
    "Trade/Device Name(s)": [
        "On Call Vivid Pro Blood Glucose Monitoring System",
        "On Call Vivid Pro Blood Glucose Meter",
        "On Call Vivid Pro Blood Glucose Test Strips",
        "On Call Vivid Pro Glucose Control Solution"
    ],
    "Submitter Information": "ACON Laboratories, Inc.",
    "510(k) Number": "K123010",
    "Predicate Device Reference 510(k) Number(s)": [
        "K002134"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "December 14, 2012",
    "Summary Letter Received Date": "September 27, 2012",
    "Submission Date": "September 26, 2012",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "On Call Vivid Pro Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical enzymatic assay",
        "Amperometric detection",
        "Glucose oxidase biosensor"
    ],
    "Methodologies": [
        "Quantitative glucose measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for On Call Vivid Pro Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood using electrochemical enzymatic assay",
    "Indications for Use Summary": "Used by healthcare professionals in health care facilities for quantitative measurement of glucose in fresh capillary whole blood from the fingertip to monitor effectiveness of diabetes control programs; not for diagnosis or screening of diabetes or use on neonates",
    "fda_folder": "Clinical Chemistry"
}